V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
Guide · Agentic AI in GxP manufacturing — safe autonomy, forbidden actions, governance

Agentic AI in Regulated Manufacturing: Where Autonomy Stops

An agent is a model that plans a sequence of actions and executes them against real systems, rather than returning text.

6 min readFor QA heads, validation leads, IT and ops directors in regulated manufacturing
Pharmaceutical production team at work

In Short

  1. 1Forget the marketing taxonomy of assistants, copilots and agents.
  2. 2There is real value on the safe side of the line.
  3. 3Batch release and material disposition are out: 21 CFR 211.22 and EU GMP place them with the quality unit and, in the EU, a named Qualified Person.
Contents
  1. The distinction that matters: reversible versus signed
  2. Safe agentic work: preparation, chasing and assembly
  3. Forbidden actions — and why the list is short but absolute
  4. The failure modes to design against
  5. Documenting the boundary for an inspector
  6. Questions to put to any vendor selling agents into your plant
  7. Questions
Contents
  1. The distinction that matters: reversible versus signed
  2. Safe agentic work: preparation, chasing and assembly
  3. Forbidden actions — and why the list is short but absolute
  4. The failure modes to design against
  5. Documenting the boundary for an inspector
  6. Questions to put to any vendor selling agents into your plant
  7. Questions

In an unregulated business that is mostly an efficiency question. In a GMP plant it is a compliance question, because a surprising proportion of the actions worth automating are signed decisions with a named accountable person attached. This guide draws the line: what an agent can safely do in regulated manufacturing, what it must never do, and how to document the boundary so it survives an inspection.

01

The distinction that matters: reversible versus signed

Forget the marketing taxonomy of assistants, copilots and agents. The only classification that matters on a regulated site is whether an action is reversible and unsigned, or whether it constitutes a regulated decision.

More on the distinction that matters: reversible versus signed

Assembling a draft, gathering evidence, opening a record in draft state, populating a form, scheduling a reminder, running a query — reversible, unsigned, safe to automate. Approving a document, releasing a batch, closing a CAPA, dispositioning material, changing a specification, overriding a tolerance, signing anything — regulated decisions with a legally accountable human behind them. An agent may prepare all of the second category. It may complete none of it.

02

Safe agentic work: preparation, chasing and assembly

There is real value on the safe side of the line. An agent can watch for a deviation with no investigation started after 24 hours and open the draft with the evidence attached.

More on safe agentic work: preparation, chasing and assembly

It can assemble the annual product review from live batch, deviation, OOS, complaint and stability data and present it for the QP to challenge. It can monitor regulatory publications, identify the changes touching your products, and raise a proposed change control. It can score supplier performance continuously and flag certificates approaching expiry. It can rank a sales worklist, draft the customer email, and prepare the inspection binder. Each of those ends with a human opening something that is already 80% done — which is where the hours actually are.

03

Forbidden actions — and why the list is short but absolute

Batch release and material disposition are out: 21 CFR 211.22 and EU GMP place them with the quality unit and, in the EU, a named Qualified Person. Electronic signature is out: under 21 CFR Part 11 a signature is bound to an individual with re-authentication and a stated meaning, and a model has no identity to bind.

More on forbidden actions — and why the list is short but absolute

CAPA closure and effectiveness verification are out, because both are judgements about whether a risk has actually been removed. Specification and tolerance change is out: that is change control, with impact assessment and approval. Audit trail modification is not merely forbidden but architecturally impossible on any system worth buying. The list is short. Its shortness is the point — everything else is available for automation, so there is no reason to argue about these five.

04

The failure modes to design against

Three specific risks separate a well-built agent from a liability. Confident error: an agent asserting something false with the same tone it uses for truth — mitigated by grounding every output in a cited record and showing the source.

More on the failure modes to design against

Version blindness: acting on a superseded procedure or an expired specification — mitigated by making effectivity a first-class constraint, not a field the model happens to read. Silent scope creep: an agent given a broad goal taking a path nobody anticipated — mitigated by defining permitted actions as an explicit allow-list rather than by instructing a model not to do things. Prompt text is not a control. Permissions are a control.

05

Documenting the boundary for an inspector

You need four things on file, and they are the same four regardless of framework. One: an intended-use statement per agent capability, narrow enough to be tested.

More on documenting the boundary for an inspector

Two: a risk assessment under GAMP 5 Second Edition classifying the capability as supporting and non-decision-making, with the consequence of a wrong output documented. Three: evidence of human review in the audit trail — every agent output recorded as accepted, edited or rejected, with the person and timestamp. Four: the permitted-action allow-list itself, held under change control, so you can show an inspector what the system is technically incapable of doing rather than arguing about intent. Under the EU AI Act, that package is broadly what documented purpose, human oversight and traceability require.

06

Questions to put to any vendor selling agents into your plant

Six questions, and the answers should be immediate. What is the technical list of actions your agent can take — not the policy, the list?

More on questions to put to any vendor selling agents into your plant

Can the agent sign, release or dispose, under any configuration? How is effectivity enforced when the agent reads a procedure? Does the audit trail distinguish a human-authored entry from an accepted AI draft? Where does inference run, and is our data used for training? What intended-use and risk documentation do you supply for validation? A vendor who answers the first question with 'it's very capable' is selling you an unbounded system, and an unbounded system in a GxP environment is a finding waiting for an inspection date.

How V5 supports this

These parts of V5 keep the records this guide describes. Your quality team decides what applies and makes the decisions.

  • QMS
  • Audits & CAPA
  • 21 CFR Part 11
  • Document control
  • Compliance Self-Assessment

Questions

Is agentic AI allowed under GMP?

Nothing prohibits AI as such. What the frameworks require is that regulated decisions are made by authorised, accountable people, that computerised systems are validated for their intended use, and that records are attributable and traceable. Agents that prepare work and stop at the signature satisfy all three. Agents that decide do not.

Can an agent open and populate a deviation on its own?

Yes — opening a draft record is reversible and unsigned. It can attach the evidence, propose root-cause lines and route it to the right owner. Classification, root cause and closure are human decisions signed on the record.

What about the EU AI Act?

For assistive, human-in-the-loop use in manufacturing quality, the practical requirements are a documented purpose, meaningful human oversight, logging and traceability of outputs. If you already hold GxP validation documentation and an audit trail recording human review, most of that package already exists.

How do we stop an agent acting on an outdated SOP?

Make effectivity a system constraint rather than a prompt instruction. The agent should only be able to retrieve the effective revision for the site and date in question, and should cite the revision in its output so a reviewer can see immediately which document it used.

Terms
  • QMS
Industry
  • Pharmaceutical
  • Medical Devices
  • Food & Beverage
  • Dietary Supplements
  • Cosmetics

Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.

Free guide33 pages · Online & printable · 4 worksheets · 16 primary sources · opens online

The Pharmaceutical Operations Guide

Right material. Right record. Released by a person.

What's inside
  • Who decides, and who may not
  • Supplier to finished bulk
  • Test, review, investigate
  • Packs, serialisation and recall

Plus Evidence map and four worksheets.

Get the pharmaceutical guide

We ask for your name and email so we can handle this request. The full guide then opens on this site, ready to translate, print or save. Privacy policy. Practical orientation, not legal advice; your quality unit decides which rules apply.

V5Ultimate

Free guide

The Pharmaceutical Operations Guide

Right material. Right record. Released by a person.

QualityTraceabilityPerformance

Keep reading

  • AI in Manufacturing Execution: What It Does Today, and What It Doesn't
  • EU AI Act (Regulation 2024/1689) for Regulated Manufacturers
  • AI and 21 CFR Part 11: Where AI Fits in Regulated Records
  • Predetermined Change Control Plans (21 U.S.C. 360e-4) for Medical Devices
  • Supplement Allergen Control: Validated Cleaning and Labelling
  • CAR T Cell Manufacturing Readiness: Chain of Identity and Release
All guides

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC

Page version 1.2· Last revised 27 Sep 2026